Anti-HGFR / c-Met Reference Antibody (onartuzumab)

Product Code: 140143

Molecular Weight:	Molecular Formula:
EC Number:	MDL Number:
Melting Point:	Boiling Point:
Density:	Storage Condition:	-20℃

Product Description: Used in targeted cancer therapy, particularly for tumors exhibiting dysregulated c-MET signaling pathway activity. Binds specifically to the extracellular domain of the c-MET receptor, blocking hepatocyte growth factor (HGF) interaction and inhibiting downstream signaling involved in tumor growth, invasion, and metastasis. Investigated in clinical trials for non-small cell lung cancer, gastric cancer, and other solid tumors, often in combination with other targeted agents or chemotherapy. Designed for intravenous administration as a humanized monoclonal antibody to minimize immunogenicity while enhancing therapeutic efficacy.

Sizes / Availability / Pricing:

Size	Availability	Price	Quantity
	10-20 days	€131.61	+ -

Anti-HGFR / c-Met Reference Antibody (onartuzumab)

Used in targeted cancer therapy, particularly for tumors exhibiting dysregulated c-MET signaling pathway activity. Binds specifically to the extracellular domain of the c-MET receptor, blocking hepatocyte growth factor (HGF) interaction and inhibiting downstream signaling involved in tumor growth, invasion, and metastasis. Investigated in clinical trials for non-small cell lung cancer, gastric cancer, and other solid tumors, often in combination with other targeted agents or chemotherapy. Designed for intravenous administration as a humanized monoclonal antibody to minimize immunogenicity while enhancing therapeutic efficacy.

Mechanism	-
Appearance	-
Longevity	-
Strength	-
Storage	-
Shelf Life	-
Allergen(s)	-
Dosage (Range)	-
Recommended Dosage	-
Dosage (Per Day)	-
Recommended Dosage (Per Day)	-
Mix Method	-
Heat Resistance	-
Stable in pH range	-
Solubility	-
Product Types	-
INCI	-

Anti-HGFR / c-Met Reference Antibody (onartuzumab)

Purchase History for

Cart